MetaCap

Alpha Teknova (TKNO) vs VolitionRX (VNRX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Alpha Teknova is the larger company by market cap ($453.1 million vs $6.6 million), about 68.7 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

TKNO versus VNRX key metrics
MetricTKNOVNRX
Share price$8.44$0.2194
Market cap$453.13M$6.60M
1-day change-3.10%-2.92%
YTD return+129.21%—
1-year return+66.22%—
5-year return-62.29%—
EPS (TTM)$-0.31$-3.80
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$9.48$12.80
52-week low$1.91$0.217
Distance from 52-week high-10.97%-98.29%
Analyst consensusstrong_buynone
Avg. price target upside+6.64%+6107.84%
Average volume230.99K8.46M
Shares outstanding53.69M30.06M
Employees15857
SectorHealthcareHealthcare
IndustryDrug Manufacturers - Specialty & GenericMedical Devices

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Alpha Teknova is about 68.7 times larger than VolitionRX by market value ($453.13M vs $6.60M).

About Alpha Teknova

TKNO stock →

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Healthcare · Drug Manufacturers - Specialty & Generic · 158 employees

About VolitionRX

VNRX stock →

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.

Healthcare · Medical Devices · 57 employees

TKNO vs VNRX FAQ

Which is bigger, Alpha Teknova or VolitionRX?

Alpha Teknova (TKNO) is larger, with a market capitalization of $453.13M compared with $6.60M for VolitionRX (VNRX).

Are Alpha Teknova and VolitionRX in the same industry?

Both are in the Healthcare sector, but in different industries: Drug Manufacturers - Specialty & Generic for Alpha Teknova and Medical Devices for VolitionRX.

More comparisons